agilon health upgraded by Jefferies with a new price target
Stocks in this Quantisnow insightHealth Care
Historical context for AGL
Across the 7 sessions after earlier AGL headlines, the stock closed higher 4 times and lower 3 times, with a median move of 8.9% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | AGL | SPY |
|---|---|---|---|
| May 7, 2026 | agilon health upgraded by Deutsche Bank with a new price target | +117.8% | -0.3% |
| May 4, 2026 | Agilon Health downgraded by Analyst with a new price target | -8.9% | -0.4% |
| Apr 28, 2026 | agilon health Appoints Tim O'Rourke as Chief Executive Officer | +10.2% | -0.5% |
| Apr 7, 2026 | agilon health Sets Date to Report First Quarter 2026 Financial Results | +18.8% | +0.0% |
| Feb 18, 2026 | agilon health to Participate in Upcoming Conferences | +6.5% | +0.5% |
| Jan 23, 2026 | agilon health Sets Date to Report Fourth Quarter and Full Year 2025 Financial Results | -1.9% | +0.0% |
Quantisnow market dataNYSE
AGL
agilon health inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Misc Health and Biotechnology Services
- Listed since
- 2021
Get push alerts for AGL
Full AGL profile on Quantisnow Follow AGL and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time